Digital Therapeutics Market Research Report by Indication (Cardiovascular Disease, Central Nervous System Disorder, and Chronic Respiratory Disease), by Component (Devices and Software), by Distribution, by Region (Americas, Asia-Pacific, and Europe, Midd

Digital Therapeutics Market Research Report by Indication (Cardiovascular Disease, Central Nervous System Disorder, and Chronic Respiratory Disease), by Component (Devices and Software), by Distribution, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

The Global Digital Therapeutics Market size was estimated at USD 2,472.67 million in 2020 and expected to reach USD 3,048.70 million in 2021, at a CAGR 23.63% to reach USD 8,830.68 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Digital Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Indication, the market was studied across Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease, Diabetes, Medication Adherence, Musculoskeletal Disorder, Obesity, Prediabetes, and Smoking Cessation.

Based on Component, the market was studied across Devices and Software.

Based on Distribution, the market was studied across B2B and B2C. The B2B is further studied across Employer, Payer, Pharmaceutical Company, and Provider. The B2C is further studied across Caregiver and Patient.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Digital Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Digital Therapeutics Market, including 2morrow Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, BigHealth, Canary Health Inc., Click Therapeutics, Cognoa, Ginger.Io, Inc., Happify, Kaia Health, Lark Technologies, Livongo Health, Inc., Mango Health Inc., Mindstrong Health, Noom Inc., Omada Health, Inc., One Drop, Pear Therapeutics, Propeller Health, Proteus Digital Health, Inc., Twine health, Inc., Vitra Health, Welldoc, Inc., and Wellthy Therapeutics.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Digital Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Digital Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Digital Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Digital Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Digital Therapeutics Market?
6. What is the market share of the leading vendors in the Global Digital Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Digital Therapeutics Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing incidences of preventive chronic diseases
5.2.2. Control on healthcare cost with focus on preventive healthcare
5.2.3. Adoption of smartphones and tablets coupled with healthcare apps
5.3. Restraints
5.3.1. Limited awareness regarding digital therapeutics in the develping economies
5.4. Opportunities
5.4.1. Huge undiagnosed and untreated population base
5.4.2. Technology to undiscover the therapeutic areas
5.5. Challenges
5.5.1. Data privacy and security concerns
6. Digital Therapeutics Market, by Indication
6.1. Introduction
6.2. Cardiovascular Disease
6.3. Central Nervous System Disorder
6.4. Chronic Respiratory Disease
6.5. Diabetes
6.6. Medication Adherence
6.7. Musculoskeletal Disorder
6.8. Obesity
6.9. Prediabetes
6.10. Smoking Cessation
7. Digital Therapeutics Market, by Component
7.1. Introduction
7.2. Devices
7.3. Software
8. Digital Therapeutics Market, by Distribution
8.1. Introduction
8.2. B2B
8.2.1. Employer
8.2.2. Payer
8.2.3. Pharmaceutical Company
8.2.4. Provider
8.3. B2C
8.3.1. Caregiver
8.3.2. Patient
9. Americas Digital Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Digital Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Digital Therapeutics Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 2morrow Inc.
13.2. Akili Interactive Labs
13.3. Ayogo Health Inc.
13.4. Better Therapeutics
13.5. BigHealth
13.6. Canary Health Inc.
13.7. Click Therapeutics
13.8. Cognoa
13.9. Ginger.Io, Inc.
13.10. Happify
13.11. Kaia Health
13.12. Lark Technologies
13.13. Livongo Health, Inc.
13.14. Mango Health Inc.
13.15. Mindstrong Health
13.16. Noom Inc.
13.17. Omada Health, Inc.
13.18. One Drop
13.19. Pear Therapeutics
13.20. Propeller Health
13.21. Proteus Digital Health, Inc.
13.22. Twine health, Inc.
13.23. Vitra Health
13.24. Welldoc, Inc.
13.25. Wellthy Therapeutics
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2026
FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2020 VS 2026 (%)
FIGURE 26. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2020 VS 2026 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2026
FIGURE 28. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (%)
FIGURE 33. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2026
FIGURE 35. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYER, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 39. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PAYER, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PAYER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL COMPANY, 2018-2026 (USD MILLION)
FIGURE 42. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL COMPANY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 43. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PROVIDER, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PROVIDER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 45. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2026 (USD MILLION)
FIGURE 46. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 47. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CAREGIVER, 2018-2026 (USD MILLION)
FIGURE 48. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CAREGIVER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 49. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENT, 2018-2026 (USD MILLION)
FIGURE 50. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 51. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. CANADA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. CHINA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. INDIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. ITALY DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. QATAR DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 80. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. GLOBAL DIGITAL THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 82. GLOBAL DIGITAL THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 83. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DIGITAL THERAPEUTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL DIGITAL THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYER, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PAYER, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL COMPANY, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PROVIDER, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CAREGIVER, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. CANADA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. CHINA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. INDIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. ITALY DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. QATAR DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. GLOBAL DIGITAL THERAPEUTICS MARKET: SCORES
TABLE 57. GLOBAL DIGITAL THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 58. GLOBAL DIGITAL THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 59. GLOBAL DIGITAL THERAPEUTICS MARKET: RANKING
TABLE 60. GLOBAL DIGITAL THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 61. GLOBAL DIGITAL THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 62. GLOBAL DIGITAL THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 63. GLOBAL DIGITAL THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 64. GLOBAL DIGITAL THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 65. GLOBAL DIGITAL THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 66. GLOBAL DIGITAL THERAPEUTICS MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook